Pneumococcal membrane particles show promise for serotype-independent vaccine protection against Streptococcus pneumoniae colonization
Despite implementation of pneumococcal conjugated vaccines (PCVs) against Streptococcus pneumoniae infections, these diseases are still major contributors to global mortality and morbidity, highlig...
Read the full article
Comments
Sign in to join the conversation.
No comments yet. Be the first.